01 January 2025 : Review article
Impact of Liver Disease on Use of Muscle Relaxants in Anesthesia: A Comprehensive Review
Paweł Radkowski



DOI: 10.12659/MSM.945822
Med Sci Monit 2025; 31:e945822
Table 1 Comparison of steatotic liver disease-connected diagnoses nomenclature, which evolved through the years with its diagnostic criteria.
NAFLD criteria | MAFLD criteria | MASLD |
---|---|---|
The presence of hepatic steatosis (verified through imaging techniques and/or histological techniques – liver biopsy);And at least one between these 3 conditions: | ||
NAFLD – non-alcoholic fatty liver disease, MAFLD – metabolic dysfunction-associated fatty liver disease, MASLD – metabolic dysfunction-associated steatotic liver disease. |